Archive for the ‘Arthritis’ Category

How is Your Health Affecting Your Quality of Life?

Monday, April 16th, 2012

New Medical Approach

That is the question that doctors are asking, in a novel new approach to health care. They are pushing for nurses and counselors to be more involved in their patients’ lives. THey are asking them less about their symptoms, and more about how those symptoms are changing their life.

Chronic disease in particular will be helped by this approach. Instead of telling diabetics they need to reach a certain blood glucose level, nurses are reminding them that they can do more, play with their grandchildren, be less tired, if they maintain a healthy level. Asthmatics are starting to understand that their condition always needs to be treated, not just when they are already wheezing. By simply talking to their patients, nurses and doctors are realizing that side effects can be worse than what they are treating, or that people have a hard time taking multiple pills in a day. By learning these things, doctors can adjust prescriptions and treatments accordingly. It makes for a happier, healthier patient.

The American government is also beginning to listen to doctors. With 75% of federally funded health care being spent on chronic care, they are beginning to understand that they should approach this differently. They are adding more funding to this personalized style of care, and the statistics say it is working.

Read more on the Wall Street Journal.

Share

Buy Vimovo

Wednesday, November 9th, 2011

the U.S. Food and Drug Administration (FDA) has approved Vimovo (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.

Vimovo, co-developed by POZEN Inc. and AstraZeneca, is a fixed-dose combination of enteric-coated naproxen, a pain-relieving non-steroidal anti-inflammatory drug (NSAID), and immediate-release esomeprazole, a proton pump inhibitor (PPI). The FDA approval was supported by data from a clinical development program, including results from the pivotal PN400-301 and PN400-302 studies, which showed patients taking Vimovo experienced significantly fewer endoscopic gastric ulcers, compared to patients receiving enteric-coated naproxen.

To read the full article of FDA Approved Vimovo For Arthritis Patients At Risk Of Developing NSAID-Associated Gastric Ulcers, please >click< here.

To buy Vimovo online, please check the product details here.

Share

Arthritis Drug a Future Diabetes Medication?

Monday, August 15th, 2011

Arthritis or Diabetes?

A collaborative group of researchers including the American Diabetes Association and the Juvenile Diabetes Research Foundation has been testing the medication abatacept (CTLA4 immunoglobin fusion protein) as a possible treatment for type 1 diabetes. Abatacept, better known by its brand name Orencia, is FDA approved to treat autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. 

Type 1 diabetes is an autoimmune disease in which T-cells in the body’s immune system mistakenly attack the insulin producing beta cells in the pancreas. With the pancreas producing little or no insulin, type 1 diabetics must rely on insulin injections to regulate their blood sugar levels. Those type 1 diabetes who continue to produce some insulin have an easier time keeping their blood sugar in the normal range, and have less risk of diabetes complications.
(more…)

Share

Myths About Arthritis And RX Drugs Which Help Fight It

Monday, December 6th, 2010

There are many myths surrounding arthritis, and the most common is the myth that only older people can suffer from arthritis. This is not true. Juvenile arthritis is the name given to arthritis which affects young people, which shows that you cannot be ‘too young’ to be affected by the illness. (more…)

Share

Cherries Prove an Effective Gout Medication

Monday, November 29th, 2010

Gout is a form of arthritis caused by elevated levels of uric acid in the blood (hyperuricemia). The excess uric acid forms painful crystals (tophi) in joints, tendons and surrounding tissues, causing recurring attacks of red, tender, hot, swollen and extremely painful joints, usually the joint at the base of the big toe. Other joints such as the ankles, heels, knees, fingers and wrists can also be affected, and crystals occasionally appear in the kidneys. Fatigue and fever sometimes accompany gout attacks. (more…)

Share

Clinical Trials Hold Promise for New Oral Rheumatoid Arthritis Medication

Thursday, November 18th, 2010

A large stage three trial of an experimental rheumatoid arthritis medication, tasocitinib, has met two important goals – the drug provided an improvement in signs and symptoms of the disease in study participants, and it improved their ability to function physically. The study also made some progress towards a third goal – disease remission.  “When it works, it really works,” enthused primary investigator Dr. Roy Fleischmann of the University of Texas Southwestern Medical Center, “This is the first oral medication for rheumatoid arthritis that has had a successful phase three study this century.”
(more…)

Share

Treatment for Osteoarthritis Remains a Challenge

Saturday, September 4th, 2010

There are over 100 types of arthritis, defined as the breakdown and wearing away of cartilage (protein-like cushion) between the joints caused by inflammation. Osteoarthritis arthritis, also called degenerative arthritis or just OA, is the most common form of arthritis, affecting over 20 million Americans. Osteoarthritis is more common in women than in men as we age, and over 30 percent of American females have some form of it by 65. (more…)

Share